RxDoctor Payments Data

Jennifer Stewart

Medical · Pineville, WVNPI 1558525774

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,040 and has fallen 55.6% since, to $461 in 2025.

$3,531in general payments, 2019–2025

Across 214 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$534
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$350
  • AbbVie$305
  • Boehringer Ingelheim$278
  • AstraZeneca$262
  • Abbott$221
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$3,531100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,531 in reported general payments places this provider in the 80th percentile of 233 medical providers in West Virginia.

See all medical providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$39,951
EliquisApixaban33$29,495
MounjaroTirzepatide15$18,759
TrulicityDulaglutide16$16,973
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$15,884
FarxigaDapagliflozin Propanediol15$10,630
Novolog FlexpenInsulin Aspart18$4,269
Albuterol Sulfate HfaAlbuterol Sulfate82$2,986
Acetaminophen-CodeineAcetaminophen With Codeine75$2,123
Ventolin HfaAlbuterol Sulfate23$1,318
Omeprazole153$1,299
Metoprolol Succinate102$852
Gabapentin77$787
Potassium Chloride84$746
Montelukast Sodium87$729

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$198$39,95143 claims
Lilly USA, LLCMounjaro, Trulicity$104$35,73231 claims
PfizerEliquis$178$29,49533 claims
GSKTrelegy Ellipta$534$15,88425 claims
AstraZenecaFarxiga$262$10,63015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 233 medical providers in West Virginia.

Other medical in Pineville

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →